JAGX HOD at .355 and 2 nice Pr's out today
Crofelemer, Jaguar Health's Prescription Drug Conditionally Approved by the FDA for Chemotherapy-Induced Diarrhea in Dogs, is the Subject of the Company's Investigational New Animal Drug Application for the Indication of General Diarrhea in Dogs
Diarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the veterinary emergency roo...
Dow Jones
May 6, 2024, 8:32 AM ET ''
Jaguar Health Applies for Investigational New Animal Drug Status for Potential Dog Diarrhea Treatment
Jaguar Health (JAGX) said Monday it initiated an Investigational New Animal Drug file with the Center for Veterinary Medicine of the US Food and Drug ...
MT Newswires
May 6, 2024, 9:04 AM ET
